ABSCINT

ABSCINT is a clinical-stage molecular imaging company that develops diagnostics based on single-domain antibodies. They specialize in advanced in vivo imaging diagnostics, focusing on innovative PET tracers to enhance specificity, precision, convenience, and safety for patients and healthcare workers, particularly in HER2 cancer care.